XML 45 R26.htm IDEA: XBRL DOCUMENT
v3.22.4

LOSS PER SHARE ("LPS") | 12 Months Ended
--- | ---
Mar. 31, 2022
LOSS PER SHARE ("LPS") |
LOSS PER SHARE ("LPS") | Note 19 – LOSS PER SHARE (“LPS”) Basic LPS is the amount of net earnings available to each share of ordinary shares outstanding during the reporting period. Diluted EPS is the amount of net earnings available to each share of ordinary shares outstanding during the reporting period adjusted to include the effect of potentially dilutive ordinary shares. The following table details the outstanding shares for basic and diluted net earnings per share: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended | ​ | Year ended | ​ | Year ended
​ |  | March 31, 2022 |  | March 31, 2021 |  | March 31, 2020
​ | ​ | USD | ​ | USD | ​ | USD
Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss from continuing operation attributable to Akso Health Group | ​ | ​ | (16,851,064) | ​ | ​ | (31,552,242) | ​ | ​ | (47,363,485)
Net loss from discontinued operation attributable to Akso Health Group | ​ | ​ | — | ​ | ​ | (3,274,747) | ​ | ​ | (23,834,894)
Net loss attributable to Akso Health Group | ​ | ​ | (16,851,064) | ​ | ​ | (34,826,989) | ​ | ​ | (71,198,379)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average number of ordinary shares outstanding-basic | ​ | ​ | 59,612,152 | ​ | ​ | 48,837,977 | ​ | ​ | 48,757,199
Weighted average number of dilutive potential ordinary shares from share options | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Weighted average number of ordinary shares outstanding-diluted | ​ | ​ | 59,612,152 | ​ | ​ | 48,837,977 | ​ | ​ | 48,757,199
Basic (loss) per common share | ​ | ​ | (0.28) | ​ | ​ | (0.71) | ​ | ​ | (1.46)
Diluted (loss) per common share | ​ | ​ | (0.28) | ​ | ​ | (0.71) | ​ | ​ | (1.46)
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration